231 related articles for article (PubMed ID: 220932)
1. Rat interferons. VI. Heterologous interferon in the treatment of viral infections.
Lobodzińska M; Albin M
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):247-52. PubMed ID: 220932
[TBL] [Abstract][Full Text] [Related]
2. Heterospecific activity of rat interferon.
Lobodzińska M; Mejbaum-Katzenellenbogen W; Biernacka I; Zamorska B; Albin M; Skurska Z
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):493-7. PubMed ID: 219806
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of different mouse interferons in mice infected with encephalomyocarditis (EMC).
Lobodzińska M; Albin M
Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):49-55. PubMed ID: 6184029
[TBL] [Abstract][Full Text] [Related]
4. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
Werner GH; Jasmin C; Chermann JC
J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
[TBL] [Abstract][Full Text] [Related]
5. The effect of experimental infection of mice with encephalomyocarditis (EMC) virus on interferon production by alveolar and peritoneal cells in vitro.
Lobodzińska M; Albin M; Skurska Z
Arch Immunol Ther Exp (Warsz); 1981; 29(1):91-5. PubMed ID: 6169322
[TBL] [Abstract][Full Text] [Related]
6. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C.
Cembrzyńska-Nowak M
Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831
[TBL] [Abstract][Full Text] [Related]
7. Effect on influenza virus infection on the production of interferon by alveolar and peritoneal cells in vitro.
Szulc B; Szalaty H
Arch Immunol Ther Exp (Warsz); 1980; 28(1):93-7. PubMed ID: 6158300
[TBL] [Abstract][Full Text] [Related]
8. Interferon and humoral immune response in experimental influenza: infection with A/PR8 virus adapted to the mouse.
Lobodzińska M; Albin M
Arch Immunol Ther Exp (Warsz); 1980; 28(2):323-8. PubMed ID: 6160829
[TBL] [Abstract][Full Text] [Related]
9. Tunicamycin enhances virus replication and inhibits antiviral activity of interferon in mice: correlation with natural killer cells.
Singh VK; Damewood GP; Friedman RM; Maheshwari RK
J Exp Pathol; 1987; 3(1):19-33. PubMed ID: 2445942
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
Ahmed M; Cramer SD; Lyles DS
Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
[TBL] [Abstract][Full Text] [Related]
11. Role of incomplete viruses and interferon in persistent infection of mouse cells with Sindbis virus.
Inglot AD; Chudzio T; Albin M
Acta Microbiol Pol A; 1973; 5(3):181-2. PubMed ID: 4358717
[No Abstract] [Full Text] [Related]
12. Interferon production and infection caused by influenza virus in radiation chimeras.
Mentkevich LM; Orlova TG; Shcheglovitova ON
Acta Virol; 1973 Sep; 17(5):435-8. PubMed ID: 4148117
[No Abstract] [Full Text] [Related]
13. Rat interferons. III. Antiviral activity and effect of "priming" on interferon production in homologous and heterologous cell lines.
Lobodzińska M; Biernacka I; Skurska Z
Arch Immunol Ther Exp (Warsz); 1975; 23(2):225-31. PubMed ID: 238487
[TBL] [Abstract][Full Text] [Related]
14. Influence of hyperthermia on experimental viral infections in vitro.
Panasiak W; Oraczewska A; Luczak M
Adv Exp Med Biol; 1990; 267():471-5. PubMed ID: 1965095
[TBL] [Abstract][Full Text] [Related]
15. Interferon and humoral immune response in experimental influenza. I. Infection with virus unadapted to the mouse.
Szalaty H; Szulc B
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):503-8. PubMed ID: 749803
[TBL] [Abstract][Full Text] [Related]
16. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.
Iwasaki T; Nozima T
J Immunol; 1977 Jan; 118(1):256-63. PubMed ID: 401512
[TBL] [Abstract][Full Text] [Related]
17. Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
Stebbing N; Grantham CA; Carey NH
J Gen Virol; 1976 Jan; 30(1):21-39. PubMed ID: 173799
[TBL] [Abstract][Full Text] [Related]
18. Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity.
Lam V; Duca KA; Yin J
Biotechnol Bioeng; 2005 Jun; 90(7):793-804. PubMed ID: 15834946
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice.
Hirasawa K; Ogiso Y; Takeda M; Lee MJ; Itagaki S; Doi K
Lab Anim Sci; 1995 Dec; 45(6):652-6. PubMed ID: 8746525
[TBL] [Abstract][Full Text] [Related]
20. Effect of human and murine neutrophils on encephalomyocarditis, vesicular stomatitis, and reo type 3 virus infections in tissue culture.
Faden HS; Keller N; Ogra PL
J Reticuloendothel Soc; 1978 Dec; 24(6):629-36. PubMed ID: 221657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
